AIM
GILD icon

Acropolis Investment Management’s Gilead Sciences GILD Stock Holding History

Acropolis Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
1,606
+24
+2% +$3.16K 0.01% 287
2026
Q1 		$220K Buy
+1,582
New +$222K 0.01% 271
2018
Q4 		– Sell
-1,610
Closed -$124K – 145
2018
Q3 		$124K Sell
1,610
-690
-30% -$52.1K 0.02% 129
2018
Q2 		$163K Sell
2,300
-185
-7% -$13.1K 0.03% 124
2018
Q1 		$187K Sell
2,485
-130
-5% -$10.3K 0.03% 122
2017
Q4 		$187K Buy
2,615
+255
+11% +$19.4K 0.03% 122
2017
Q3 		$191K Sell
2,360
-3,310
-58% -$253K 0.03% 115
2017
Q2 		$401K Sell
5,670
-10,805
-66% -$719K 0.07% 97
2017
Q1 		$1.12M Buy
16,475
+120
+0.7% +$8.44K 0.2% 60
2016
Q4 		$1.17M Buy
16,355
+1,770
+12% +$132K 0.22% 59
2016
Q3 		$1.15M Buy
14,585
+280
+2% +$22.7K 0.21% 53
2016
Q2 		$1.19M Buy
14,305
+965
+7% +$85.6K 0.23% 52
2016
Q1 		$1.23M Buy
13,340
+3,110
+30% +$280K 0.24% 51
2015
Q4 		$1.03M Buy
10,230
+3,930
+62% +$409K 0.21% 57
2015
Q3 		$619K Buy
+6,300
New +$700K 0.13% 75

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acropolis Investment Management's GILD Position: Q2 2026 in Review

Acropolis Investment Management increased its Gilead Sciences (GILD) stake by 1.5% in Q2 2026, buying an estimated $3.16K and bringing the position to 1,606 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #287.

Acropolis Investment Management first reported a position in GILD in Q3 2015 and has held it in 15 quarters since. The position peaked at $1.23M in Q1 2016. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Acropolis Investment Management held 1,606 shares of Gilead Sciences worth $203K as of Q2 2026.
  • Acropolis Investment Management bought 24 Gilead Sciences shares in Q2 2026, an estimated $3.16K.
  • Gilead Sciences made up 0.01% of Acropolis Investment Management's portfolio in Q2 2026, its #287 holding.
  • Acropolis Investment Management first reported a position in Gilead Sciences in Q3 2015 and has held it in 15 quarters since.
  • Acropolis Investment Management's Gilead Sciences position peaked at $1.23M in Q1 2016.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Acropolis Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.